Mark Feldman
Hebrew University of Jerusalem
ORCID: 0000-0003-4448-3991Also affiliated with Carmel Medical Center
Medicine
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 1 paper. Top paper: βEngineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activityβ.
0 citations
Naama Rotenberg, Julia M. Shifman, Mark Feldman